Search

everythinglearnresearchcommunity

for

Search:↓

Local hormonal treatment for vulvovaginal atrophy is likely safe for women with estrogen receptor-positive breast cancer on aromatase inhibitors.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

The exact cause of increased 5α-reductase activity leading to hirsutism in women is still unknown.

Topical eflornithine effectively reduces unwanted facial hair in women with hirsutism for at least 6 months.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

Orthognathic surgeons play a key role in modifying masculine facial features to be more feminine, often improving transgender women's quality of life.

Idiopathic hirsutism is the most common cause of hirsutism in women, followed by PCOS.

Hair transplantation is important for transgender patients to enhance their masculine or feminine appearance.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

A multidisciplinary approach is crucial for safe and effective hormone treatment in gender-dysphoric individuals, with specific guidelines for adolescents and adults.

The discovery of 5α-reductase deficiency in guevedoces led to the development of important urologic medications.

Most women with excess hair growth had Polycystic Ovary Syndrome, and severity wasn't linked to hormone levels.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

Cyproterone acetate at 2mg daily is as effective as higher doses for treating excessive hair growth in women.

Diane is effective for treating acne, seborrhoea, androgenic alopecia, and mild hirsutism in women.

Using finasteride 0.5% solution with laser therapy significantly reduces unwanted facial hair in women.

An mFG score of 5 or more indicates above-normal hair growth in Southern Chinese women.

Measuring plasma testosterone glucosiduronate is a reliable way to detect high male hormone levels in women.

Elevated luteinizing hormone contributes to female-pattern hair loss, and blocking certain channels may help prevent it.

Higher doses of oestradiol implants improve bone density in postmenopausal women.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Fennel extract cream can reduce hair thickness in people with excessive hair growth.

A woman's increased facial hair and hair loss were caused by a rare ovarian tumor, cured by surgery.

A woman's virilization symptoms were caused by her partner's use of testosterone cream, which resolved after they separated.

Cyproterone acetate is effective for treating hirsutism and acne in women by blocking androgens in the skin and also works as a contraceptive.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.